JAK2V617F allele burden is reduced by busulfan therapy: A new observation using an old drug.
Times cited: 19
JAK2V617F allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy.
Times cited: 36
Evaluation of JAK2V617F in B and T cell neoplasms: Identification of JAK2V617F mutation of undetermined significance (JMUS) in the bone marrow of three individuals.
Times cited: 17
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders.
Journal of Molecular Diagnostics.
Times cited: 46